Trial intelligence / Profile preview

Efficacy of ketorolac on success rate of dental anesthesia in symptomatic irreversible pulpitis

IRCT2015042616845N2Phase 2Completed

Sponsor
Office of the Vice Chancellor for Research
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ketorolac in irreversible pulpitis, sponsored by Office of the Vice Chancellor for Research. Started Mar 2015; status: completed.

02

Drugs

ketorolac
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on IRCT2015042616845N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015042616845N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call